Printer Friendly

Survival with HAART.

A study from Denmark suggests that the death rates in people with HIV have fallen significantly since 1995--since the introduction of highly active antiretroviral therapy (HAART). The latest figures suggest that a 25-year-old with HIV can now expect to survive for more than 35 years, although concurrent infection with hepatitis C reduces this survival to around 32 years.

These estimates are obtained from a cohort of all Danish adults with HIV--but do depend on HAART continuing to work well through life. The authors say that they have found no evidence of HAART becoming less effective with time, despite potential problems with multidrug resistance and serious side-effects. This means that the prognosis for those with HIV--in the developed world--approaches that associated with type 1 diabetes. However, even in Denmark, the outlook for those living with HIV remains far worse than the outlook for healthy people. In this study the current mortality rates for young adults with HIV were 9-15 times higher than the rates for age-matched adults without HIV.

Lohse N, et al. Ann Intern Med 2007; 146: 87-95.
COPYRIGHT 2007 South African Medical Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:single suture; highly active antiretroviral therapy
Author:Lohse, N.
Publication:CME: Your SA Journal of CPD
Article Type:Brief article
Geographic Code:4EUDE
Date:Mar 1, 2007
Words:178
Previous Article:Press much more, blow much less--new international resuscitation guidelines: the new guidelines have been formulated in the light of understanding...
Next Article:Management of stimulant drug overdose: substance abuse is one of the most pervasive problems in modern culture.
Topics:


Related Articles
Maine Medicaid Plan Will Provide Early Treatment for HIV.
Surviving with HIV in the HAART era: emerging challenges.
HIV-treating physicians in Houston express their professional opinions on the public health implications of antiretroviral therapy.
NEWS BRIEFS.
Retroviruses Conference: Johns Hopkins Report.
Can treatment during primary HIV infection lead to control of disease without drugs?
HIV-associated malignancies have become increasingly important with the spread of HIV infection.
Implementation and effectiveness of antiretroviral therapy in Greenland.
Vertical transmission rate is low when pregnant women get HIV therapy.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters